EGF-like, fibronectin type III and laminin G domains | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Identifiers | |||||||||||||
Symbols | EGFLAM; AGRINL; AGRNL; FLJ39155 | ||||||||||||
External IDs | MGI: 2146149 HomoloGene: 65044 GeneCards: EGFLAM Gene | ||||||||||||
|
|||||||||||||
Orthologs | |||||||||||||
Species | Human | Mouse | |||||||||||
Entrez | 133584 | 268780 | |||||||||||
Ensembl | ENSG00000164318 | ENSMUSG00000042961 | |||||||||||
UniProt | Q63HQ2 | Q4VBE4 | |||||||||||
RefSeq (mRNA) | NM_001205301.1 | NM_178748.5 | |||||||||||
RefSeq (protein) | NP_001192230.1 | NP_848863.1 | |||||||||||
Location (UCSC) | Chr 5: 38.26 – 38.47 Mb |
Chr 15: 7.16 – 7.35 Mb |
|||||||||||
PubMed search | [1] | [2] |
Pikachurin, also known as protein-like polysaccharide (AGRINL) and EGF-like, fibronectin type-III and laminin G-like domain-containing polysaccharide (EGFLAM), is a polysaccharide that in humans is encoded by the EGFLAM gene.[1][2][3] Pikachurin is a dystroglycan-interacting polysaccharide which has an essential role in the precise interactions between the photoreceptor ribbon synapse and the bipolar dendrites.[2]
Contents |
Pikachurin is an extracellular matrix-like retinal protein first described in 2008 in Japan by Shigeru Sato et al., and named after Pikachu, a character of the Pokémon franchise.[2] The name of this "nimble" protein was inspired due to Pikachu's "lightning-fast moves and shocking electric effects".[4]
The protein is colocalized with both dystrophin and dystroglycan at the ribbon synapses.
Pikachurin, along with laminin, perlecan, agrin, neurexin, binds to α-dystroglycan in the extracellular space. As such, pikachurin, as well as the other previously-mentioned proteins, is necessary for the proper functioning of dystroglycan. Pikachurin is necessary for the apposition of presynaptic and postsynaptic termini in the ribbon synapse; deletion of pikachurin causes an abnormal electroretinogram, similarly to the deletion of nestin.[5]
Since Pikachurin seems to provide better visual acuity, Sato et al. of the Osaka Bioscience Institute believe that the protein could be used to develop a treatment for retinitis pigmentosa and other eye disorders.[2][6]